Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.

Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.

Despite recent advances in cancer treatment over the past 30 years, therapeutic options remain limited and do not always offer a cure for malignancy. Given that tumor-associated antigens (TAA) are, by definition, self-proteins, the need to productively engage autoreactive T cells remains at the hear...

Bibliografski detalji
Glavni autori:	Sachamitr, P, Hackett, S, Fairchild, P
Format:	Journal article
Jezik:	English
Izdano:	2014

Slični predmeti

Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
od: Patty eSachamitr, i dr.
Izdano: (2014-04-01)

Exploiting the use of induced pluripotent stem cell derived immune cells for immunotherapy
od: Sachamitr, S
Izdano: (2015)

Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
od: Sachamitr, P, i dr.
Izdano: (2018)

Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
od: Sachamitr, P, i dr.
Izdano: (2012)

Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
od: Patty Sachamitr, i dr.
Izdano: (2018-01-01)

The challenge of immunogenicity in the quest for induced pluripotency.
od: Fairchild, P
Izdano: (2010)

Induced Pluripotent Stem Cells in Birds: Opportunities and Challenges for Science and Agriculture
od: Nousheen Zahoor, i dr.
Izdano: (2024-12-01)

iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
od: Horton, C, i dr.
Izdano: (2019)

The Opportunities and Challenges regarding Induced Platelets from Human Pluripotent Stem Cells
od: Meng-Xue Xu, i dr.
Izdano: (2021-01-01)

Emerging opportunities for induced pluripotent stem cells in orthopaedics
od: Wan-Ju Li, i dr.
Izdano: (2019-04-01)

Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management
od: Cossins, C, i dr.
Izdano: (2021)

Haplobanking induced pluripotent stem cells for clinical use
od: Sullivan, S, i dr.
Izdano: (2020)

Embryonic stem cells: protecting pluripotency from alloreactivity.
od: Fairchild, P, i dr.
Izdano: (2007)

T cell immunotherapy for cervical cancer: challenges and opportunities
od: Lingfeng Yu, i dr.
Izdano: (2023-04-01)

Role of T cells in cancer immunotherapy: Opportunities and challenges
od: Hossain Ahmed, i dr.
Izdano: (2023-04-01)

Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy
od: Hiroaki Mashima, i dr.
Izdano: (2021-06-01)

Transplantation tolerance in an age of induced pluripotency.
od: Fairchild, P
Izdano: (2009)

Human induced pluripotent stem cell-derived cardiomyocytes as an electrophysiological model: Opportunities and challenges—The Hamburg perspective
od: Djemail Ismaili, i dr.
Izdano: (2023-02-01)

Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities
od: Tae Wan Kim, i dr.
Izdano: (2020-08-01)

Pluripotency of induced pluripotent stem cells
od: Kang Lan, i dr.
Izdano: (2012-02-01)

Human induced pluripotent stem cells are capable of B-cell lymphopoiesis.
od: Carpenter, L, i dr.
Izdano: (2011)

Induced pluripotent stem cells for development of cancer immunotherapy - A viable idea for less toxic treatment
od: Prof. Binafsha Manzoor Syed
Izdano: (2022-06-01)

Obtaining consent for future research with induced pluripotent cells: opportunities and challenges.
od: Katriina Aalto-Setälä, i dr.
Izdano: (2009-02-01)

Addressing the immunological barriers to regenerative medicine: differentiation and characterisation of dendritic cells derived from induced pluripotent stem cells
od: Hackett, S
Izdano: (2013)

Regeneration of T cells from human-induced pluripotent stem cells for CAR-T cell medicated immunotherapy
od: Yanyan Chen, i dr.
Izdano: (2023-05-01)

The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications
od: Amr A. Youssef, MD, PhD, i dr.
Izdano: (2016-10-01)

Prospects and challenges of induced pluripotent stem cells in equine health
od: Francesc Xavier eDonadeu, i dr.
Izdano: (2015-11-01)

Interconversion of Cancer Cells and Induced Pluripotent Stem Cells
od: Drishty B. Sarker, i dr.
Izdano: (2024-01-01)

Natural killer cell memory: challenges and opportunities for cancer immunotherapy
od: Yuhua Qu, i dr.
Izdano: (2024-12-01)

Induced Pluripotent Stem Cells
od: Chia-Yu Chang, i dr.
Izdano: (2018-11-01)

Induced Pluripotent Stem Cell-Based Cancer Vaccines
od: Xiaoming Ouyang, i dr.
Izdano: (2019-07-01)

Ovarian cancer immunotherapy: opportunities, progresses and challenges
od: Stevens Richard, i dr.
Izdano: (2010-02-01)

Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
od: Huang Zhu, i dr.
Izdano: (2019-08-01)

Cancer stem cells and niches: challenges in immunotherapy resistance
od: Yonglong Pan, i dr.
Izdano: (2025-02-01)

T–cell–based immunotherapy for osteosarcoma: challenges and opportunities
od: Zhan Wang, i dr.
Izdano: (2016-09-01)

Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
od: Guilian Shi, i dr.
Izdano: (2019-12-01)

Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research
od: Hsiao-Mei Chao, i dr.
Izdano: (2018-12-01)

Induced pluripotent stem cells in dentistry
od: Paramel Mohan Sunil
Izdano: (2016-01-01)

Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges
od: Sara Guerreiro, i dr.
Izdano: (2023-02-01)

Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease
od: Manoj Kumar Jaiswal
Izdano: (2017-01-01)